Edit |   |
Antigenic Specificity | NLRP3 (NALP3), Human/Mouse |
Clone | REA668 |
Host Species | Recombinant Human |
Reactive Species | human, mouse |
Isotype | IgG1 |
Format | phycoerythrin (PE) conjugate |
Size | 100 tests in 200 µL |
Concentration | 1:50 |
Applications | Intracellular flow cytometry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | NLRP3 (NALP3) Antibody, anti-human/mouse, PE, REAfinity™. Clone REA668 recognizes the human and mouse NLRP3 antigen, also known as NACHT, LRR, and PYD domains-containing protein 3 (NALP3). NLRP3, a member of the NLR family of cytosolic receptors, is a pyrin-like protein which contains a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. NLRP3 plays a crucial role in innate immunity and inflammation and is a pathogen recognition receptor (PRR) that recognizes pathogen-associated molecular patterns (PAMPs). NLRP3 is an important regulator of caspase-1, the enzyme that processes the immature form of IL-1β into the active protein. NLRP3 is mainly expressed in macrophages, but also expressed in dendritic cells, B cells, T cells, and osteoblasts. | Additional information: Clone REA668 displays negligible binding to Fc receptors. |
Immunogen | n/a |
Other Names | NACHT, LRR, PYD domains-containing protein 3, NALP3, cryopyrin |
Gene, Accession # | Gene ID: 114548, 216799 |
Catalog # | 130-111-209 |
Price | $310 |
Order / More Info | NLRP3 (NALP3), Human/Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | McCall, S. H. et al. (2008) Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. J. Bone Miner. Res. 23 (1): 30-40. | Bae, J. Y. et al. (2011) Crystal structure of NALP3 protein pyrin domain (PYD) and its implications in inflammasome assembly. J. Biol. Chem. 286 (45): 39528-39536. | Haneklaus, M. et al. (2013) Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr. Opin. Immunol. 25 (1): 40-45. |